Association between Psychiatric Disorders and Glomerular Disease.

Hailey E Desmond, Clare Lindner, Jonathan P Troost, Zack Held, Andrea Callaway, Gia J Oh, Richard Lafayette, Michelle O'Shaughnessy, Matthew Elliott, Sharon G Adler, Elaine S Kamil, Anne Pesenson, David T Selewski, Patrick E Gipson, Noelle E Carlozzi, Debbie S Gipson, Susan F Massengill
{"title":"Association between Psychiatric Disorders and Glomerular Disease.","authors":"Hailey E Desmond,&nbsp;Clare Lindner,&nbsp;Jonathan P Troost,&nbsp;Zack Held,&nbsp;Andrea Callaway,&nbsp;Gia J Oh,&nbsp;Richard Lafayette,&nbsp;Michelle O'Shaughnessy,&nbsp;Matthew Elliott,&nbsp;Sharon G Adler,&nbsp;Elaine S Kamil,&nbsp;Anne Pesenson,&nbsp;David T Selewski,&nbsp;Patrick E Gipson,&nbsp;Noelle E Carlozzi,&nbsp;Debbie S Gipson,&nbsp;Susan F Massengill","doi":"10.1159/000516359","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Patients with chronic health conditions, particularly chronic kidney disease, are at heightened risk for psychiatric disorders; yet, there are limited data on those with primary glomerular disease.</p><p><strong>Methods: </strong>This study included patients with glomerular disease enrolled in the kidney research network multisite patient registry. Registry data include encounter, diagnoses, medication, laboratory, and vital signs data extracted from participants' electronic health records. ICD-9/10 diagnosis codes were used to identify a subset of psychiatric disorders focused on anxiety, mood, and behavioral disorders. Time-varying Cox proportional hazard models were used to analyze time from the onset of kidney disease to diagnosis of psychiatric disorder. Adjusted models retained significant covariates from the full list of potential confounders, including age, sex, race, ethnicity, time-varying treatment, the estimated glomerular filtration rate, and proteinuria (urine protein-to-creatinine ratio [UPCR]). Analogous models examined diagnosis of psychiatric disorder as a predictor of time to end-stage kidney disease (ESKD).</p><p><strong>Results: </strong>Data were available for 950 participants, with a median of 58 months of follow-up. 110 (12%) participants were diagnosed with psychiatric disorder during the follow-up. The estimated rate of psychiatric diagnosis after kidney disease was 14.7 cases per 1,000 person-years and was highest among those of adolescent age at the time of kidney disease diagnosis. Adjusted analyses found adolescent age (vs. adult, hazard ratio [HR] = 3.11, 95% confidence interval [CI] 1.87-5.17) and Asian race (vs. white, HR = 0.34, 95% CI 0.16-0.71) were associated with psychiatric diagnosis. A higher UPCR per 1 log unit (HR 1.13, 95% CI 1.01-1.27) and a higher total number of oral medications were associated with psychiatric disorder (<i>p</i> < 0.001). Psychiatric diagnosis was also associated with progression to ESKD (HR = 2.45, 95% CI 1.53-3.92) in adjusted models.</p><p><strong>Discussion/conclusion: </strong>Psychiatric disorders were documented in approximately one-eighth of patients with glomerular disease and correlated with clinical disease characteristics such as age, race, proteinuria, and oral medication burden. These findings suggest mental health screening is warranted in patients of all ages with glomerular disease.</p>","PeriodicalId":73177,"journal":{"name":"Glomerular diseases","volume":"1 3","pages":"118-128"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000516359","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Glomerular diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000516359","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Introduction: Patients with chronic health conditions, particularly chronic kidney disease, are at heightened risk for psychiatric disorders; yet, there are limited data on those with primary glomerular disease.

Methods: This study included patients with glomerular disease enrolled in the kidney research network multisite patient registry. Registry data include encounter, diagnoses, medication, laboratory, and vital signs data extracted from participants' electronic health records. ICD-9/10 diagnosis codes were used to identify a subset of psychiatric disorders focused on anxiety, mood, and behavioral disorders. Time-varying Cox proportional hazard models were used to analyze time from the onset of kidney disease to diagnosis of psychiatric disorder. Adjusted models retained significant covariates from the full list of potential confounders, including age, sex, race, ethnicity, time-varying treatment, the estimated glomerular filtration rate, and proteinuria (urine protein-to-creatinine ratio [UPCR]). Analogous models examined diagnosis of psychiatric disorder as a predictor of time to end-stage kidney disease (ESKD).

Results: Data were available for 950 participants, with a median of 58 months of follow-up. 110 (12%) participants were diagnosed with psychiatric disorder during the follow-up. The estimated rate of psychiatric diagnosis after kidney disease was 14.7 cases per 1,000 person-years and was highest among those of adolescent age at the time of kidney disease diagnosis. Adjusted analyses found adolescent age (vs. adult, hazard ratio [HR] = 3.11, 95% confidence interval [CI] 1.87-5.17) and Asian race (vs. white, HR = 0.34, 95% CI 0.16-0.71) were associated with psychiatric diagnosis. A higher UPCR per 1 log unit (HR 1.13, 95% CI 1.01-1.27) and a higher total number of oral medications were associated with psychiatric disorder (p < 0.001). Psychiatric diagnosis was also associated with progression to ESKD (HR = 2.45, 95% CI 1.53-3.92) in adjusted models.

Discussion/conclusion: Psychiatric disorders were documented in approximately one-eighth of patients with glomerular disease and correlated with clinical disease characteristics such as age, race, proteinuria, and oral medication burden. These findings suggest mental health screening is warranted in patients of all ages with glomerular disease.

Abstract Image

Abstract Image

Abstract Image

精神疾病与肾小球疾病的关系
慢性疾病患者,特别是慢性肾病患者,患精神疾病的风险较高;然而,关于原发性肾小球疾病的数据有限。方法:本研究纳入肾脏研究网络多站点患者登记的肾小球疾病患者。注册数据包括从参与者的电子健康记录中提取的就诊、诊断、用药、实验室和生命体征数据。ICD-9/10诊断代码用于识别集中于焦虑、情绪和行为障碍的精神障碍子集。采用时变Cox比例风险模型分析从肾脏疾病发病到精神障碍诊断的时间。调整后的模型保留了潜在混杂因素完整列表中的重要协变量,包括年龄、性别、种族、民族、时变治疗、估计肾小球滤过率和蛋白尿(尿蛋白与肌酐比值[UPCR])。类似的模型检验了精神障碍诊断作为终末期肾病(ESKD)时间预测因子。结果:950名参与者的数据可用,中位随访时间为58个月。110名(12%)参与者在随访期间被诊断为精神障碍。肾脏疾病后的精神病诊断率估计为每1000人年14.7例,在肾脏疾病诊断时的青少年中最高。校正分析发现,青少年年龄(相对于成年人,风险比[HR] = 3.11, 95%可信区间[CI] 1.87-5.17)和亚洲种族(相对于白人,风险比[HR] = 0.34, 95%可信区间[CI] 0.16-0.71)与精神病诊断相关。较高的UPCR / 1 log单位(HR 1.13, 95% CI 1.01-1.27)和较高的口服药物总数与精神障碍相关(p < 0.001)。在调整后的模型中,精神病学诊断也与ESKD进展相关(HR = 2.45, 95% CI 1.53-3.92)。讨论/结论:大约八分之一的肾小球疾病患者存在精神障碍,并与临床疾病特征(如年龄、种族、蛋白尿和口服药物负担)相关。这些发现表明,对所有年龄的肾小球疾病患者进行精神健康筛查是必要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信